China SXT Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
China SXT Pharmaceuticals, Inc. (SXTC) reported Debt Conversion, Converted Instrument, Amount of $956.88 thousand for the 12-month period ending 2020-03-31, per its 20-F filed 2020-07-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-07-31
| Period end | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|
| 2020-03-31 | $956.88K 20-F · filed 2020-07-31 | |
| 2019-09-30 | $699.03K 6-K/A · filed 2020-05-22 |